This Just In-
Two new pharmacy benefit management companies decided to enter the market, promising to facilitate greater drug price transparency: EmsanaRx and also the Mark Cuban Cost Plus Drug Company.
Pharmacy benefit managers (PBMs) work with insurance companies, pharmacies, and manufacturers to negotiate the lowest drug costs for his or her members. Drug Channels Institute estimates that in 2022 about 77 percent of prescription claims ran through the top three PBMs – CVS Health, the Express Scripts business of Cigna, and also the OptumRx business of UnitedHealth Group.
EmsanaRx is really a nonprofit coalition of just about 40 companies planning to offer pharmacy benefit management services to employers. EnsanaRx, including retailers such as Walmart and Costco, may be the PBM unit from the Purchaser Business Group on Health (PBGH) coalition. Emsana Health intends to serve as an “innovation studio” which will develop services and solutions with input from PBGH's employer members.
The goal of the Mark Cuban Cost Plus Drug Company is to sell generic drugs in a transparent, fixed rate, and to unite manufacturing, distribution, and pharmacy services under one roof. The PBM plans to be running by 2023, according to an article in the Wall Street Journal.
